Metagenomi Therapeutics Inc.

XNAS:MGX   4:00:00 PM EDT
1.25
+0.06 (+5.04%)
4:10:05 PM EDT: $1.25 0.00 (0.00%)
Twitter Share  Facebook Share StockTwits Share

Search For a Symbol

Market Cap (Intraday)47.06M
Current PEN/A
Forward PE N/A
2yr Forward PE N/A
See more stats
Estimates Current Quarter
Revenue$3.36 Million
Adjusted EPS-$0.58
See more estimates
10-Day MA$1.32
50-Day MA$1.39
200-Day MA$1.79
See more pivots

Metagenomi Inc. Stock, XNAS:MGX

5959 Horton Street, 7th floor, Emeryville, California 94608
United States of America
Phone: +1.510.871.4880
Number of Employees: 202
http://www.metagenomi.co

Description

Metagenomi, Inc. is a precision genetic medicines company, which engages in the business of developing next generation gene-editing technologies and therapies. Its business activities include developing gene edit�­ing toolbox, ther�­a�­peu�­tic focus, and processing discovery platform. The company was founded by Brian C. Thomas on September 16, 2016 and is headquartered in Emeryville, CA.